Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis. (Record no. 30722952)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01917 a2200517 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518091254.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202109s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1476-5608 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/s41391-020-0222-6 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mori, Keiichiro |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210916 |
| 245 00 - TITLE STATEMENT | |
| Title | Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Prostate cancer and prostatic diseases |
| Date of publication, distribution, etc. | 12 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 539-548 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Meta-Analysis; Systematic Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Androgen Antagonists |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Androstenes |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzamides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials, Phase II as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kallikreins |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nitriles |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenylthiohydantoin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostate-Specific Antigen |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostatic Neoplasms, Castration-Resistant |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Miura, Noriyoshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mostafaei, Hadi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Quhal, Fahad |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sari Motlagh, Reza |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pradere, Benjamin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kimura, Shoji |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kimura, Takahiro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Egawa, Shin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Briganti, Alberto |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karakiewicz, Pierre I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shariat, Shahrokh F |
| 773 0# - HOST ITEM ENTRY | |
| Title | Prostate cancer and prostatic diseases |
| Related parts | vol. 23 |
| -- | no. 4 |
| -- | p. 539-548 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/s41391-020-0222-6">https://doi.org/10.1038/s41391-020-0222-6</a> |
| Public note | Available from publisher's website |
No items available.